GLP1R and Alzheimer disease: In a 3xTg mice model of AD, semaglutide promoted glycolysis, ameliorated memory impairment, and reduced β-amyloid plaques and neurofibrillary tangles via GLP-1R/SIRT1/GLUT4 pathway, resulting in better metabolism balance and cognition [130].